Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Simran Farms Ltd

SIMRAN
BSE
159.60
1.01%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Simran Farms Ltd

SIMRAN
BSE
159.60
1.01%
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
77Cr
Close
Close Price
159.60
Industry
Industry
Hatcheries
PE
Price To Earnings
PS
Price To Sales
0.09
Revenue
Revenue
864Cr
Rev Gr TTM
Revenue Growth TTM
17.65%
PAT Gr TTM
PAT Growth TTM
-110.32%
Peer Comparison
How does SIMRAN stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
SIMRAN
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
103106119123138176175245238205188233
Growth YoY
Revenue Growth YoY%
21.413.142.442.034.367.146.798.772.116.27.9-5.1
Expenses
ExpensesCr
95104115128138164174245243203187230
Operating Profit
Operating ProfitCr
824-401211-4213
OPM
OPM%
7.41.93.5-3.60.27.00.40.3-1.80.80.81.2
Other Income
Other IncomeCr
000011000111
Interest Expense
Interest ExpenseCr
110000001111
Depreciation
DepreciationCr
000010000000
PBT
PBTCr
714-501210-5112
Tax
TaxCr
111-10400-2000
PAT
PATCr
613-30900-3101
Growth YoY
PAT Growth YoY%
55.7500.0157.9-230.1-96.71,353.3-91.9104.2-1,705.0-91.345.8714.3
NPM
NPM%
5.90.62.5-2.70.14.90.10.1-1.40.40.20.5
EPS
EPS
15.91.67.8-8.90.523.00.60.4-8.52.00.93.0

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
444447410341320281322394367486834864
Growth
Revenue Growth%
23.40.7-8.3-16.8-6.2-12.114.622.2-6.832.571.53.6
Expenses
ExpensesCr
438440401330310307297382360484825863
Operating Profit
Operating ProfitCr
67101110-2625117291
OPM
OPM%
1.31.62.33.13.2-9.37.82.91.90.41.10.2
Other Income
Other IncomeCr
000000031222
Interest Expense
Interest ExpenseCr
356321222214
Depreciation
DepreciationCr
222222222222
PBT
PBTCr
10256-292210318-2
Tax
TaxCr
00112-890002-1
PAT
PATCr
11144-221310406-1
Growth
PAT Growth%
30.4-32.144.4307.20.8-628.3158.6-18.4-65.0-88.91,376.2-116.3
NPM
NPM%
0.20.10.21.21.3-7.73.92.61.00.10.7-0.1
EPS
EPS
2.71.82.610.610.7-56.733.227.19.41.015.6-2.5

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
444444444444
Reserves
ReservesCr
12131418221132427273338
Current Liabilities
Current LiabilitiesCr
10412297717484747484106147170
Non Current Liabilities
Non Current LiabilitiesCr
972233112122
Total Liabilities
Total LiabilitiesCr
129146118961039292102117139189214
Current Assets
Current AssetsCr
11012698738163707789112163188
Non Current Assets
Non Current AssetsCr
192019232229222528272726
Total Assets
Total AssetsCr
129146118961039292102117139189214

Cash Flow

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
-13-1741016-711-2-78-11
Investing Cash Flow
Investing Cash FlowCr
-5-3-1-6-1-2-10-4-1-2
Financing Cash Flow
Financing Cash FlowCr
2019-4-100-200-13
Net Cash Flow
Net Cash FlowCr
2-1-1315-98-3-106-10
Free Cash Flow
Free Cash FlowCr
-17-212315-99-3-107-14
CFO To PAT
CFO To PAT%
-1,268.1-2,416.3378.5237.0393.532.683.8-23.5-187.82,048.7-189.9
CFO To EBITDA
CFO To EBITDA%
-220.8-226.139.589.4156.626.941.8-21.4-98.0396.0-121.8

Ratios

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
136164925102464354365
Price To Earnings
Price To Earnings
13.29.316.012.26.20.01.96.29.7111.211.0
Price To Sales
Price To Sales
0.00.00.00.10.10.00.10.20.10.10.1
Price To Book
Price To Book
0.80.40.92.21.02.31.42.31.11.41.8
EV To EBITDA
EV To EBITDA
6.26.95.47.33.4-1.11.36.78.531.811.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
19.418.919.921.421.910.324.417.919.117.615.7
OPM
OPM%
1.31.62.33.13.2-9.37.82.91.90.41.1
NPM
NPM%
0.20.10.21.21.3-7.73.92.61.00.10.7
ROCE
ROCE%
9.68.113.715.914.5-82.952.221.69.13.811.7
ROE
ROE%
6.44.25.518.415.7-495.173.837.611.71.316.0
ROA
ROA%
0.80.50.84.23.9-23.513.710.13.10.33.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Simran Farms Limited is a prominent Indian integrated poultry enterprise specializing in **poultry breeding, farming, and hatchery operations**. The company operates a vertically integrated "feed-to-fork" business model, focusing on the consolidation of poultry activities through large-scale **contract farming** and internal manufacturing infrastructure. By maintaining control over the entire value chain—from feed production to broiler rearing—the company ensures quality standards and operational oversight in a rapidly modernizing sector. --- ### **Integrated Value Chain & Operational Infrastructure** The company’s operations are designed to mitigate supply chain volatility through vertical integration and strategic partnerships. * **Core Product Focus:** The company operates in a single identifiable segment—**Poultry Breeding & Farming**—with its primary commercial output being **broilers**. * **Contract Farming Model:** Simran Farms utilizes an integration model with local farmers, providing them with scientific rearing protocols and balanced nutrition management to ensure high-yield bird production. * **Feed Self-Sufficiency:** The company operates a large-scale manufacturing setup for **poultry feeds** to support internal requirements. * **Strategic Sourcing (Simran Agritech):** Sourcing is optimized through **Simran Agritech Private Limited (SAPL)**, which operates an automatic manufacturing plant for **Soya DOC** and poultry feed. This partnership provides feed with high **protein ratios**, improving bird strength and yield. * **Logistics Optimization:** Manufacturing plants are strategically located in close proximity to poultry farms to minimize **transportation costs** and reduce bird stress during transit. * **Subsidiary Operations:** The company holds an **82.71%** stake in **Puregene Biotech Limited**, which reported total assets of **₹406.07 Lakhs** and a net profit of **₹10.12 Lakhs** for the year ended March 31, 2025. --- ### **Financial Performance & Growth Trajectory** Simran Farms has demonstrated a significant recovery in revenue and profitability, navigating through a period of high commodity volatility. | Metric (Standalone) | FY 2024-25 | FY 2023-24 | FY 2022-23 | | :--- | :--- | :--- | :--- | | **Total Income** | **₹836.24 Crore** | **₹488.69 Crore** | **₹367.27 Crore** | | **Net Profit (PAT)** | **₹5.79 Crore** | **₹31.12 Lakhs** | **₹3.49 Crore** | | **Revenue Growth** | **+71.1%** | **+33.06%** | **-6.75%** | **Performance Drivers:** * The recent surge in net profit is attributed to **improved price realization for broilers**, **better feed conversion ratios (FCR)**, and **reduced disease incidence**. * Despite revenue growth in FY24, margins were previously pressured by a **32% annual surge** in maize prices. * The company reported **no cash losses** for FY 2023-24 or the preceding year. --- ### **Capital Structure & Strategic Financial Expansion** To support its growth targets and navigate a consolidating industry, the company has significantly strengthened its capital base and financial flexibility. **1. Equity Capital Expansion:** In **March 2026**, the company converted **1,018,300 warrants** into equity shares at an issue price of **₹155** (including a **₹145 premium**). This raised **INR 15.78 Crores** from both the **Promoter Group** and **Non-Promoters**, increasing the paid-up equity capital to **₹4.81 Crore** (**48,10,000 shares**). **2. Enhanced Borrowing & Investment Limits:** * **Borrowing Limit:** Increased from **₹100.00 Crore** to **₹150.00 Crore** as of November 2025. * **Investment & Loan Limit:** Authorized up to **INR 50 Crores** under Section 186 of the Companies Act to allow for strategic loans and securities. * **Related Party Transactions (RPT):** Approved transactions with **Simran Agritech Private Limited** for an aggregate value of up to **INR 600 Crores** for **FY 2025-26**, ensuring a steady supply of raw materials at arm’s length. **3. Liquidity & Liability Profile (as of March 31, 2025):** The company manages liquidity through rolling cash flow forecasts and committed credit lines. | Liability Type (₹ in Lakhs) | Less than 1 year | 1-3 Years | More than 3 years | Total | | :--- | :--- | :--- | :--- | :--- | | **Trade Payables** | **8,650.71** | 565.27 | 536.30 | **9,752.28** | | **Short Term Borrowings** | **4,129.63** | — | — | **4,129.63** | | **Long Term Borrowings** | — | 15.01 | 0.29 | **15.31** | --- ### **Industry Outlook & Strategic Targets** India is the world's **third-largest producer** of poultry meat and eggs. Simran Farms is positioned to capitalize on the sector's transition toward organized, integrated models. * **Sector Growth:** Indian poultry demand is projected to grow **8-10%** in **FY 2025-26**, with a long-term **CAGR of 8.1%** through **2034**. * **Company Targets:** Management is targeting a **4-6% volume growth** and an **8-10% revenue increase** in the forthcoming fiscal year. * **Macro Tailwinds:** Leveraging India's projected **7.20% GDP growth** for **FY 2024-25** and rising consumer preference for affordable, protein-rich diets. --- ### **Risk Profile & Mitigation Strategies** The poultry industry is characterized by high biological and commodity risks. Simran Farms employs a formal **Risk Management Policy** to address these headwinds. **1. Operational & Biological Risks:** * **Feed Costs:** Raw materials (**Maize and Soybean meal**) constitute over **60%** of production costs. The company uses **forward contracts** to hedge against price spikes. * **Disease Management:** Vulnerability to **Avian Influenza (Bird Flu)** is mitigated through stringent **biosecurity protocols** and comprehensive **vaccination programs**. * **Climate Impact:** Heat waves can increase mortality; the company maintains **comprehensive insurance coverage** for livestock and assets. **2. Market & Financial Risks:** * **Price Volatility:** Broiler realization prices are volatile; management notes a limited ability to fully pass on cost increases to consumers. * **Credit Risk:** Managed through individual customer creditworthiness assessments and established credit limits. The company has **no foreign exchange exposure**. **3. Governance & Compliance:** * **Regulatory Note:** As of September 2025, the company noted a deficiency in maintaining the required database for **Unpublished Price Sensitive Information (UPSI)** regarding subsidiary financials. * **Leadership:** Continuity is maintained through the re-appointment of **Mr. Kawaljeet Singh Bhatia** (until August 2027) and **Mr. Gurmeet Singh Bhatia** (until August 2026) as Whole Time Directors.